Synageva BioPharma Corp $79.38

down 0.00


16/4/2014 08:10 PM  |  NASDAQ : GEVA  
Industries : Drugs / Biotechnology

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D10,000$0.9564.42%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-1,050$85.76-6.34%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D10,000$23.0039.18%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-10,675$82.80-30.05%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-3,529$83.50-14.20%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-4,746$84.72-22.26%
3/12/2014Heberlig ChrisGroup Vice President, Finance820$0.9540.16%
3/12/2014Heberlig ChrisGroup Vice President, Finance5,000$23.00174.70%
3/12/2014Heberlig ChrisGroup Vice President, Finance-3,933$98.49-54.91%
3/12/2014Heberlig ChrisGroup Vice President, Finance-3,037$99.08-94.05%
3/12/2014Heberlig ChrisGroup Vice President, Finance1,850$1.70963.54%
3/12/2014Heberlig ChrisGroup Vice President, Finance-700$96.75-8.90%
3/06/2014BAKER JULIANSenior Executive Officer9,031$105.754.46%
3/06/2014BAKER JULIANSenior Executive Officer365,969$105.754.69%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-1,745$103.05-66.12%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-894$104.22-100.00%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-3,207$102.18-54.86%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-3,081$101.14-34.51%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-1,000$100.07-10.07%
1/29/2014Patel Sanj KPresident & CEO50,971$3.524,943.84%
1/29/2014Patel Sanj KPresident & CEO-24,817$87.19-47.72%
1/29/2014Patel Sanj KPresident & CEO-18,652$88.31-68.61%
1/29/2014Patel Sanj KPresident & CEO-5,600$89.27-65.63%
1/29/2014Patel Sanj KPresident & CEO-1,502$90.85-51.21%
1/29/2014Patel Sanj KPresident & CEO-400$91.58-27.95%
1/28/2014Patel Sanj KPresident & CEO6,106$0.95592.24%
1/28/2014Patel Sanj KPresident & CEO24,832$3.52347.93%
1/28/2014Patel Sanj KPresident & CEO20,391$1.7063.78%
1/28/2014Patel Sanj KPresident & CEO-9,506$87.16-18.16%
1/28/2014Patel Sanj KPresident & CEO-32,609$88.38-76.09%
1/28/2014Patel Sanj KPresident & CEO-8,402$88.95-82.01%
1/28/2014Patel Sanj KPresident & CEO-812$90.10-44.06%
12/31/2013Quinn AnthonyEVP, CMO & Head of R&D192$36.301.25%
12/31/2013Williams GlenSVP, Technical Operations132$36.3098.51%
12/31/2013Goldberg Mark AlanEVP, Medical & Reg. Strategy192$36.3071.91%
12/03/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-413$61.02-60.74%
12/03/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-6,587$60.49-90.64%
12/02/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-3,861$53.98-38.89%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-1,765$54.97-29.10%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-3,801$55.99-88.37%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-500$57.20-100.00%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,695$49.61-50.85%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,205$50.34-89.73%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-100$51.04-27.25%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,770$64.61-93.39%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,230$63.97-44.45%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
9/25/2013BAKER FELIXSenior Executive Officer25,663$56.6314.51%
9/25/2013BAKER FELIXSenior Executive Officer1,024,337$56.6315.10%
8/21/2013BOESS CARSTENSVP, Chief Financial Officer-6,681$47.19-100.00%
8/20/2013BOESS CARSTENSVP, Chief Financial Officer2,173$23.0038.62%
8/20/2013BOESS CARSTENSVP, Chief Financial Officer-7,800$47.04-100.00%
8/16/2013BOESS CARSTENSVP, Chief Financial Officer-4,300$47.47-100.00%
7/29/2013Patel Sanj KPresident & CEO-15,895$47.39-93.91%
7/29/2013Patel Sanj KPresident & CEO15,895$3.521,541.71%
7/26/2013Patel Sanj KPresident & CEO35,308$3.52193.63%
7/26/2013Patel Sanj KPresident & CEO16,882$1.7031.53%
7/26/2013Patel Sanj KPresident & CEO-17,204$48.31-94.35%
7/26/2013Patel Sanj KPresident & CEO-52,190$47.91-74.11%
7/25/2013Patel Sanj KPresident & CEO-14,711$48.73-44.65%
7/25/2013Patel Sanj KPresident & CEO20,000$1.70154.49%
7/25/2013Patel Sanj KPresident & CEO3,664$0.9539.47%
7/25/2013Patel Sanj KPresident & CEO8,251$0.95800.29%
7/16/2013Heberlig ChrisVice President, Finance-2,029$48.26-100.00%
7/15/2013Heberlig ChrisVice President, Finance1,877$0.95290.11%
7/15/2013Heberlig ChrisVice President, Finance247$0.9561.75%
7/15/2013Heberlig ChrisVice President, Finance-495$49.15-19.61%
7/11/2013BOESS CARSTENSVP, Chief Financial Officer-13,237$47.06-100.00%
6/28/2013Quinn AnthonySVP, Chief Medical Officer297$35.681.98%
6/12/2013Patel Sanj KPresident & CEO14,731$1.7055.27%
6/12/2013Patel Sanj KPresident & CEO25,621$0.952,485.06%
6/12/2013Patel Sanj KPresident & CEO-40,352$40.48-97.51%
6/11/2013Patel Sanj KPresident & CEO6,105$0.9524.84%
6/11/2013Patel Sanj KPresident & CEO23,543$0.952,283.51%
6/11/2013Patel Sanj KPresident & CEO-29,648$40.89-96.64%
4/08/2013Patel Sanj KPresident & CEO-21,695$49.49-95.46%
4/08/2013Patel Sanj KPresident & CEO21,695$0.952,104.27%
4/05/2013Patel Sanj KPresident & CEO-9,910$50.11-90.58%
4/05/2013Patel Sanj KPresident & CEO9,910$0.95961.20%
4/04/2013Patel Sanj KPresident & CEO-18,580$50.12-80.92%
4/04/2013Patel Sanj KPresident & CEO-1,200$51.64-53.79%
4/04/2013Patel Sanj KPresident & CEO-2,151$50.72-49.09%
4/04/2013Patel Sanj KPresident & CEO21,931$0.952,127.16%
4/03/2013Patel Sanj KPresident & CEO7,000$0.9566.70%
4/03/2013Patel Sanj KPresident & CEO-400$54.44-27.95%
4/03/2013Patel Sanj KPresident & CEO-1,500$53.37-51.18%
4/03/2013Patel Sanj KPresident & CEO-4,358$52.55-59.79%
4/03/2013Patel Sanj KPresident & CEO9,464$0.95917.94%
4/03/2013Patel Sanj KPresident & CEO-10,206$51.09-58.34%
4/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-619$54.92-100.00%
4/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,797$54.21-85.98%
4/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs3,091$0.95233.28%
3/01/2013Goldberg Mark AlanSVP, Product Development-2,704$50.39-61.22%
3/01/2013Goldberg Mark AlanSVP, Product Development-1,713$51.35-100.00%
2/21/2013Patel Sanj KPresident & CEO-45,392$49.02-97.78%
2/21/2013Patel Sanj KPresident & CEO45,392$0.954,402.72%
2/20/2013Patel Sanj KPresident & CEO-18,654$49.49-72.76%
2/20/2013Patel Sanj KPresident & CEO5,954$0.9530.25%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (GEVA), click here.
Trading Center